# Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

> **NCT02849691** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 747 (actual)

## Conditions studied

- Dipeptidyl-peptidase-4
- STEMI
- PCI
- No-reflow
- Bleeding

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02849691
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 747 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849691, "Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02849691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*